Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting

Dementia and Geriatric Cognitive Disorders

Volumn 19, Issue 5-6, 2005, Pages 305-315

  Sicras, A ^a   Rejas, J ^b   Arco, S ^c   Flores, E ^d   Ortega, G ^e   Esparcia, A ^e   Suarez A ^c   Gordillo, M J ^d  

^a Badalona Serveis Assistencials SL   (Spain)

^b PFIZER INC   (United States)

^c Prim Care Hlth Ctr Apenins M   (Spain)

^d Prim Care Hlth Center Morera Pomar   (Spain)

^e Prim Care Hlth Ctr Tiana Montgat   (Spain)

Author keywords

Alzheimer's dementia; Cost study; Prevalence of dementia; Resource utilization; Vascular dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CLINICAL EXAMINATION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; POPULATION RESEARCH; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; VALIDATION PROCESS;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CROSS-SECTIONAL STUDIES; DEMENTIA, VASCULAR; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SERVICES FOR THE AGED; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; SPAIN;

EID: 18644376752     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084556     Document Type: Article

References (50)

1. Fondo de Investigación Sanitaria: Epidemiología del envejecimiento en España. Madrid, Ministerio de Sanidad y Consumo, 1990.
2. Casado D: Los efectos del envejecimiento demográfico sobre el gasto sanitario: mitos y realidades. Gac Sanit 2000;15:154-163.
3. Perkins P, Annegers JF, Doody RS, Cooke N, Aday L, Vernon SW: Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology 1997;49:44-50.
4. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorenson P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A: Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999;53:1992-1997.
5. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR: Prevalence of dementia and probable senile dementia of the Alzheimer type in Framingham study. Neurology 1992;42:115-119.
6. Rocca WA, Kokmen E: Frequency and distribution of vascular dementia. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S9-S14.
7. Leys D, Pasquier F, Parnetti L: Epidemiology of vascular dementia. Haemostasis 1998;28: 134-150.
8. Jorm AF, Jolley D: The incidence of dementia: A meta-analysis. Neurology 1998;51:728-733.
9. Hebert R, Brayne C: Epidemiology of vascular dementia. Neuroepidemiology 1995;14:240-257.
10. García García FJ, Sánchez Ayalab MI, Pérez Martín A, et al: Prevalencia de demencia y de sus subtipos principales en sujetos mayores de 65 años: Efecto de la educación y ocupación. Estudio Toledo. Med Clín (Bare) 2001;116: 401-407.
11. Limón Ramírez E, Argimon Pallàs JM, Vila Doménech J, Abos Pueyo T, Cabezas Peña C, Vinyoles Bargalló E: Detección del deterioro cognitivo en población mayor de 64 años: Primera fase del proyecto Cuida'l. Aten Primaria 2003;32:6-12.
12. Coria F, Gómez JA, Minguez L, Rodríguez-Artalejo F, Clavería LE: Prevalence of age-associated memory impairment and dementia in a rural community. J Neurol Neurosurg Psychiatry 1993;56:973-976.
13. Bermejo F, Portera A, Gabriel R, et al: The prevalence of dementia and cognitive impairment in three sites in central Spain. A door-to-door study in the elderly. Neuroepidemiology 1997;16:257-270.
14. Pi J, Olivé JM, Roca J, Masana LL: Prevalence of dementia in a semi-rural population of Catalunya, Spain. Neuroepidemiology 1996;15: 33-41.
15. Bermejo F, Morales JM, Valerga C, Del Ser T, Artolazábal J, Gabriel R: Comparación entre dos versiones españolas abreviadas de evaluación del estado mental en el diagnóstico de demencia. Datos de un estudio en ancianos residentes en la comunidad. Med Clin (Barc) 1999;112:330-334.
16. Skoog I: Status of risk factors for vascular dementia. Neuroepidemiology 1998;17:2-9.
17. Peila R, Rodriguez BL, Launer LJ: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002;51:1256-1262.
18. Moore MJ, Zhu CW, Clipp EC: Informal cost of dementia care: Estimates from the National Longitudinal Caregiver Study. J Gerontol B Psychol Sci Soc Sci 2001;56:S219-S228.
19. Gutterman EM, Markowitz JS, Lewis B, Fillit H: Cost of Alzheimer's disease and related dementia in managed medicare. J Am Geriatr Soc 1999;47:1065-1071.
20. Hill JW, Futterman R, Duttagupta S, Mastey V, Lloyd JR, Fillit H: Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology 2002;58: 62-70.
21. Wimo A, Ljunggren G, Winblad B: Cost of dementia and dementia care: A review. Int J Geriatr Psychiatry 1997;12:841-856.
22. Boada M, Peña-Casanova J, Bermejo F, Guillén F, Hart WM, Espinosa C, Rovira J: Coste de los recursos sanitarios de los pacientes en régimen ambulatorio diagnosticados de enfermedad de Alzheimer en España. Med Clin (Barc) 1999;113:690-695.
23. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: A randomised trial. Lancet 2002;359:1265-1266.
24. Jonsson L, Lindgren P. Wimo A, Jonsson B, Winblad B: The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: A Markov model. Clin Ther 1999;21: 1230-1240.
25. Wimo A, Winblad B, Engedal K, Soininen H, Verhey F, Waldemer G, Wetterhorn AL, Masley V, Haglund A, Zhang R, Miceli R, Chin W, Subbiah P: An economic evaluation of donepezil in mild to moderate Alzheimer's disease: Results of a 1-year, double-blind, randomized trial. Dement Geriatr Cogn Disord 2003;15: 44-54
26. Fillit HM, Gutterman EM, Brooks RL: Impact of donepezil on caregiving burden for patients with Alzheimer's disease. Intl Psychogeriatr 2000;12:389-401.
27. Fillit HM, Hill J: The costs of vascular dementia: A comparison with Alzheimer's disease. J Neurol Sci 2002;203-204:35-39.
28. Kronborg AC, Sogaard J, Hansen E, Kragh-Sorenson A, Hastrup L, Anderson J, Anderson K, Lolk A, Niclson H, Kragh-Sorenson P: The cost of dementia in Denmark: The Odense Study. Dement Geriatr Cogn Disord 1999;10: 295-304.
29. Wimo A, Winblad B: Societal burden and economics of vascular dementia: Preliminary results from a Swedish population-based study. Int Psychogeriatr 2003;15(suppl 1):251-256.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
31. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
32. Lamberts H, Wood M: Clasificación internacional de la atención primaria CIAP-2. Clasificacion de razones de consulta. Barcelona, Masson/SG;1990.
33. Folstein MF, Folstein SE, McHugh PR: Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
34. Lobo A, Ezquerra J, Burgada FG, Sala JM, Seva A: El Mini-Examen Cognoscitivo (un test sencillo práctico para detectar alteraciones intelectuales en pacientes medicos). Actas LusoEsp Neurol Psiquiatr 1979;7:189-202.
35. Thompson SG, Barber JA: How should cost data in pragmatic randomized trials be analyzed? BMJ 2000;320:1197-1200.
36. Vinyoles Bargalló E, Vila Domènech J, Argimon Pallàs JM, Espinàs Boquet J, Abos Pueyo T, Limón Ramírez E: Concordancia entre el Mini-Examen Cognoscitivo y el Mini-Mental State Examination en el cribado del déficit cognitivo. Aten Primaria 2002;30:5-15.
37. Marcos T, Salamero M, de Azpiazu P, Pujol J, Boget T, Peri JM, Lázaro ML: Patrón de déficit neuropsicológico en la demencia tipo Alzheimer y en la demencia vascular. Med Clin (Barc) 2000;114:566-570.
38. Frank A, Pohjasvara T, Erkinjuntti T, Barreiro P, Díez-Tejedor E: Trastomos cognitivos relacionados con la isquemia cerebral. Rev Clin Esp 1996;196:51-61.
39. Ramos-Estébanez C, Hernández Hernández JL, Muñoz Arrondo R, Alonso Valle H: Enfermedad de Binswanger o demencia multiinfarto? Claves diagnósticas en la demencia vascular. Rev Clin Esp 2002;202:7-11.
40. Aharon-Peretz J, Kliot D, Tomer R: Behavioral differences between white matter lacunar dementia and Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:294-298.
41. Finkel SI: Behavioral and psychologic symptoms of dementia. Clin Geriatr Med 2003;19: 799-824.
42. Wilkinson D, Doody R, Helme R, Tautman K, Mintzer J, Kertesz A, Pratt RD, Donepezil 308 Study Group: Donepezil in vascular dementia. Neurology 2003;61:479-486.
43. Black S, Roman GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R, Donepezil 307 Vascular Dementia Study Group: Efficacy and tolerability of donepezil in vascular dementia. Positive results of a 24-week multicentre, international, randomized, placebo-controlled clinical trial. Stroke 2003;34:2323-2330.
44. Winblad B, Jelic V: Treating the full spectrum of dementia with memantine. Int J Geriatr Psychiatry 2003;18:S41-S46.
45. Moretti R, Moretti R, Torre P, Antonello RM, Cazzato G, Bava A: Rivastigmine in subcortical vascular dementia: An open 22-month study. J Neurol Sci 2002;203-204:141-146.
46. López-Arrieta JM, Birks J: Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database of Systematic Reviews. (1):CD000147, 2001.
47. Sha MC, Callahan CM: The efficacy of pentoxifylline in the treatment of vascular dementia: A systematic review. Alzheimer Dis Assoc Disord 2003;17:46-54.
48. Hill J, Fillit HM, Futterman R, Shah SN: Healthcare cost of vascular dementia in community-dwelling patients. Neurology 2004;62 (suppl 5): A234 (abstract P03.113).
49. Kurz A, Hautp M, Pollmann S, Romero B: Enfermedad de Alzheimer: Hay datos de la existencia de subtipos fenomenológicos? Observaciones de un estudio longitudinal. Dementia 1993;3:144-151.
50. Sicras Mainar A: Impacto económico de las enfermedades y pacientes atendidos en atención primaria. Adaptación de los Grupos Clínicos Ajustados (ACGs) en nuestro medio; Tesis doctoral. Universidad de Barcelona, 2002.